IN THEIR INITIAL FINANCIAL REPORTING FOR 2024, in vitro diagnostics (IVD) company leaders shared priorities and progress in the first quarter (Ql) while also acknowledging heightened competition in diagnostics. And, for some of the IVD manufacturers, a need for new leaders and perspective is being addressed. Here is a summary of recent financials, key accomplishments, […]
Global IVD Companies Report First Quarter 2024 Earnings
IVD companies release first financial reports, market results were uneven across the 12 firms
- By Robert Michel
- > From the Volume XXXI, No. 9 - July 1, 2024 Issue
- Tags: Abbott Laboratories, Alzheimer’s disease, Aperio GT 450 DX Digital Pathology slide scanner, automated ID/AST, BACT/Alert, Bayer, BD, Beckman Coulter Diagnostics, Becton Dickinson and Company, Bernd Montag PhD, Bio-Rad Laboratories, BioFire, bioMerieux, breakthrough device designation, Brian Blaser, Camtech Health, Cepheid, cervical cancer, companion diagnostic, COVID-19 test, Danaher, Elecsys pTau217, FACSDiscover, FDA, first quarter, GeneXpert, Hologic, i-STAT Alinity, i-STAT TBI, immunoassay, in vitro diagnostics, integrated diagnostics, IVD, Jim Berry, lab intelligence, leica biosystems, life sciences, Marc Casper, Matt Sause, microbiology, molecular biology, multiplex vaginal panel, MVP test, Norman Schwartz, Onclairity HPV assay, plasma biomarker test, precision cancer therapy, Q1, Qiagen, QuantiFERON, QuidelOrtho, Rainer Blair, Robert Ford, Roche Group, Roop Lakkaraju, Siemens Healthineers, SPOTFIRE, sysmex, Thermo Fisher Scientific, Thierry Bernard, Thomas Schinecker PhD, Tom Polen, US Food and Drug Administration, VITEK, Xpert Xpress
